USA - NYSE:GSK - US37733W2044 - ADR
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 6.06B | 2.95B | 5.31B | 4.92B | 5.10B | |||
| Depreciation Amortization | 3.54B | 2.55B | 2.29B | 2.15B | 2.38B | |||
| Income Taxes - Deferred | undefined | null | null | null | null | |||
| Accounts Payable And Accrued Liabilities | undefined | undefined | undefined | undefined | undefined | |||
| Change In Working Capital | -3.11B | -452.00M | -2.83B | -2.10B | -773.00M | |||
| Interest Paid | 631.00M | 632.00M | 766.00M | 848.00M | 786.00M | |||
| Taxes Paid | 1.05B | 1.31B | 1.33B | 1.31B | 1.29B | |||
| Other non cash items | 1.30B | 1.50B | 1.99B | 2.43B | 1.25B | |||
| OPERATING CASH FLOW | 7.79B | 6.55B | 6.77B | 7.40B | 7.95B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.10B | -2.98B | -2.34B | -2.26B | -2.93B | |||
| Other Investing Activity | -1.32B | 1.75B | 749.00M | -6.51B | 1.15B | |||
| INVESTING CASH FLOW | -4.42B | -1.23B | -1.59B | -8.77B | -1.78B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 980.00M | -1.39B | -2.57B | -4.82B | -2.21B | |||
| Stock Issued/Repurchased | -1.11B | 20.00M | 10.00M | 25.00M | 21.00M | |||
| Dividend Paid | -2.53B | -2.44B | -2.25B | -3.47B | -4.00B | |||
| Other Financing Activity | -1.01B | -910.00M | -837.00M | 9.09B | -1.40B | |||
| FINANCING CASH FLOW | -3.67B | -4.73B | -5.64B | 823.00M | -7.59B | |||
| Exchange Rate Effect | 29.00M | -54.00M | -99.00M | 152.00M | -29.00M | |||
| CHANGE IN CASH | -269.00M | 545.00M | -567.00M | -394.00M | -1.44B | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 7.79B | 6.55B | 6.77B | 7.40B | 7.95B | |||
| Capital Expenditure | -3.10B | -2.98B | -2.34B | -2.26B | -2.93B | |||
| FREE CASH FLOW | 4.70B | 3.57B | 4.42B | 5.14B | 5.02B | |||
All data in GBP